Jeffrey H. Knapp
2016
In 2016, Jeffrey H. Knapp earned a total compensation of $3.4M as Chief Operating Officer at Aimmune Therapeutics.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $120,500 |
| Option Awards | $2,798,900 |
| Salary | $343,750 |
| Stock Awards | $71,500 |
| Total | $3,409,650 |
Knapp received $2.8M in option awards, accounting for 82% of the total pay in 2016.
Knapp also received $75K in bonus, $120.5K in non-equity incentive plan, $343.8K in salary and $71.5K in stock awards.
Rankings
In 2016, Jeffrey H. Knapp's compensation ranked 2,729th out of 14,075 executives tracked by ExecPay. In other words, Knapp earned more than 80.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,729 out of 14,075 | 81st |
Division Manufacturing | 942 out of 5,489 | 83rd |
Major group Chemicals And Allied Products | 277 out of 1,895 | 85th |
Industry group Drugs | 202 out of 1,538 | 87th |
Industry Pharmaceutical Preparations | 154 out of 1,176 | 87th |
Source: SEC filing on April 11, 2018.
Knapp's colleagues
We found three more compensation records of executives who worked with Jeffrey H. Knapp at Aimmune Therapeutics in 2016.